colorectal carcinoma (CRC) research hub

A study to test different doses of BI 765049 in people with advanced cancer of the colon, rectum, stomach, or pancreas

This early-stage clinical trial tests a new drug called BI 765049. It is for adults with advanced cancer of the bowel, stomach, or pancreas. Doctors want to find out what dose is safe, learn how the body handles the drug, and look for any early signs that it helps.